Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue

Internal Medicine

Volumn 39, Issue 4, 2000, Pages 320-323

  Ooiwa, Hiroshi ^a   Miyazawa, Teruomi ^a   Yamanishi, Yuji ^b   Hiyama, Keiko ^b   Ishioka, Shinichi ^b   Yamakido, Michio ^b  

^a HIROSHIMA CITY HOSPITAL   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Beraprost sodium; Epoprostenol sodium; Vasoreactivity

Indexed keywords

BERAPROST; CORTICOSTEROID; PROSTACYCLIN;

ADULT; ARTICLE; CASE REPORT; DYSPNEA; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUNG ARTERY PRESSURE; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN;

EID: 0034028687     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.320     Document Type: Article

References (13)

1. Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: Clinical features of its subgroups. Chest 88: 129-135, 1985.
2. Groen H, Bootsma H, Postma DS, Kallenberg CG. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol 20: 1055-1057, 1993.
3. Kawaguchi Y, Hara M, Harigai M, Sakurada M, Nakamura H, Kashiwazaki S. Corticosteroid pulse therapy in a patient with SLE and pulmonary hypertension. Clin Exp Rheumatol 16: 510, 1998.
4. Levy RD, Guerraty AJ, Yacoub MH, Loertscher R. Prolonged survival after heart-lung transplantation in systemic lupus erythematosus. Chest 104: 1903-1905, 1993.
5. Asherson RA, Hegenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonay hypertension in a lupus clinic: experience with 24 patients. J Rheumatol 17: 1292-1298, 1990.
6. Kanemoto N, Sato M, Moriuchi J, Ichikawa Y, Goto Y, Sasadaira H. An autopsied case of systemic lupus erythematosus with pulmonary hypertension -a case report. Angiology 39: 187-192, 1988.
7. Fraser RS, Müller NS, Colman N, Par PD. Thrombosis and thromboembolism. in: Diagnosis of Diseases of the Chest. 4th ed. W.B. Saunders Company, Philadelphia, 1999: 1773-1843.
8. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 336: 111-117, 1997.
9. 2). Respir Physiol 47: 351-364, 1982.
10. Cremona G, Higenbottam T. Role of prostacyclin in the treatment of primary pulmonary hypertension. Am J Cardiol 75: 67A-71A, 1995.
11. Okano Y, Yoshioka T, Shimouchi A, Satoh T, Kunieda T. Orally active prostacyclin analogue in primary pulmonary hypertension. Lancet 349: 1365, 1997.
12. Nagaya N, Uematsu M, Okano Y, et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. J Am Coll Cardiol 34: 1188-92, 1999.
13. Lawrence EC. Systemic lupus erythematosus and the lung. in: Systemic Lupus Erythematosus. 3rd ed. Lahita RG, Ed. Academic Press, San Diego, 1999: 719-731.